On the importance of public data – an ELIXIR report
Public open data is crucial for research in the life sciences industry. ELIXIR’s latest report zooms in on that and on the role SMEs and start-ups play in building an open data ecosystem.
“Smarter and FAIR data can change lives, from patient
to researchers and even beyond. Interoperability is crucial for making sense out of public, internal and third party data.”
Public bioinformatics data is hugely important for research in our industry. It enables innovation to happen across company boundaries that would otherwise be much more difficult. At ONTOFORCE, we’ve build our business entirely around the importance of opening up data and making it searchable to as many people and organizations as possible.
That’s also the focus of the ELIXIR report: ‘Public data resources as a business model for SMEs – THE ROLE OF PUBLIC BIOINFORMATICS INFRASTRUCTURE IN SUPPORTING INNOVATION IN THE LIFE SCIENCES’.
This report highlights companies whose business model is fundamentally based on selling services on top of public data. The existence of this vibrant and fast-developing SME ecosystem in the life sciences is yet to be acknowledged as such. We’re glad that we were able to contribute to the ELIXIR report and be featured as a prime example of maximizing public data for new healthcare discoveries.
Check it out!
ELIXIR is an intergovernmental organisation that brings together life science resources from across Europe. ELIXIR includes 21 members and over 180 research organizations. It was founded in 2014, and is currently implementing its first five-year scientific programme. An ELIXIR Node is a collection of research institutes within a member country. ELIXIR Nodes run the resources and services that are part of ELIXIR. EMBL (European Molecular Biology Laboratory) is an intergovernmental organization so it is the only Node that is not associated with a country.